Serum Versus Tissue SIRT1 as Potentially Valuable Biomarkers in Gastric Cancer. Otsuka R, Morishita H, Iida K, Hayano K, et al. Anticancer Res 2023;43:1485-1491.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Otsuka R, Morishita H, Iida K, Hayano K, et al. Serum Versus Tissue SIRT1 as Potentially Valuable Biomarkers in Gastric Cancer. Anticancer Res 2023;43:1485-1491.
PMID: 36974791